Advancing Gene Therapies: FDA's Milestone Approval for Duchenne Muscular Dystrophy Treatment
The Rise of iPSCs in Drug Discovery: Regulatory and Legislative Changes Driving the Shift from Animal Models
FDA Modernization Act 2.0: FDA no longer requires all drugs to be tested on animals before human trials
Optimization of the Ncyte Astrocyte Kit
iCone Consortium hits milestone in large-scale production of iPSC-derived cortical neurons
INSPIRE: A European safety pharmacology training network
Subscribe to our newsletter
Stay up to date on iPSC innovations, events and news.
